IDO1 and neoplasm: It has been increasingly recognised that indoleamine-2,3-dioxygenase (IDO) and tryptophan-2,3-dioxygenase (TDO), which catabolise tryptophan into kynurenine, is commonly upregulated in tumours and this is thought to facilitate tumour immune evasion [36].